Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Express Scripts
Farmers Insurance
Covington
Harvard Business School

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 7,495,030

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,495,030
Title:(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
Abstract: (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid, salts thereof, and compositions containing the same for the delivery of active agents are provided. Methods of administration, treatment of disease and preparation are provided as well.
Inventor(s): Gschneidner; David (Stamford, CT)
Assignee: Emisphere Technologies, Inc. (Cedar Knolls, NJ)
Application Number:10/363,726
Patent Claims:see list of patent claims

Details for Patent 7,495,030

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX Orphan search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Try a Free Trial Emisphere Technologies, Inc. (Cedar Knolls, NJ) 2020-10-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,495,030

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 0219969 Jul 11, 2002
World Intellectual Property Organization (WIPO) 0219969 Mar 14, 2002
United States of America 2004023847 Feb 05, 2004
European Patent Office 1322595 Jul 02, 2003
European Patent Office 1322595 Mar 23, 2005
European Patent Office 1322595 May 28, 2008
Germany 60134245 Jul 10, 2008
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
US Army
Merck
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.